Advertisement

Senescence pp 105-109 | Cite as

Discussion of Dr. Croce’s Paper

  • Orlando J. Miller
Part of the Cellular Senescence and Somatic Cell Genetics book series (CSSCG, volume 2)

Abstract

Carlo Croce has presented very convincing evidence that SV40 viral expression and malignancy are dominant in mouse-human hybrid cells. He has shown that the virus integrated into chromosome 7 in three independently transformed human lines and into chromosome 17 in a fourth. Clearly there is not a single site of integration, and one wonders whether chromosome 7 (or 17, for that matter) has more than one site of SVM-0 integration. This question could be answered by mapping the integration site, much as one would map any other gene locus, by starting with cell lines in which chromosome 7 has been split into two parts by a translocation, or by inducing breaks in chromosome 7 by irradiating hybrid cells in which there is still a diploid mouse complement and the only human chromosome present is a number 7 carrying an integrated SV40 viral genome.

Keywords

Hybrid Cell Murine Leukemia Virus Teratocarcinoma Cell SV40 Virus Normal Diploid Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chattopadhyay, S.K., Rowe, W.P., Teich, N.M., and Lowry, D.R.: Definitive evidence that murine C-type virus inducing locus Akv-1 is viral genetic material. Proc. Nat. Acad. Sci. U.S.A. 72: 906–910 (1975).CrossRefGoogle Scholar
  2. Fenyö, E.M., Nazerian, K., and Klein, E.: Characteristics-of murine C-type viruses. II. The behavior of viruses resident in various cell lines and their hybrids on BALB/3T3 and mouse embyro fibroblast cultures. Virology 59: 574–579 (1974).PubMedCrossRefGoogle Scholar
  3. Huang, A.S., Besmer, P., Chu, L., and Baltimore, D.: Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J. Virol. 12: 659–662 (1973).PubMedGoogle Scholar
  4. Jolicoeur, P., and Baltimore D.: Effect of Fv-1 gene product on synthesis of N-tropic and B-tropic murine leukemia viral RNA. Cell 7: 33–39 (1976).PubMedCrossRefGoogle Scholar
  5. Ketner, G., and Kelly, T.J., Jr.: Integrated simian virus 40 sequences in transformed cell DNA: analysis using restriction endonucleases. Proc. Nat. Acad. Sci. U.S.A. 73: 1102–1106 (1976).CrossRefGoogle Scholar
  6. Mintz, B., and Illmensee, K.: Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Nat. Acad. Sci. U.S.A. 72 3585–3589 (1975).CrossRefGoogle Scholar
  7. Papaioannou, V.E., McBurney, M.W., Gardner, R.L., and Evans, M.J.: Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258: 70–73 (1975).PubMedCrossRefGoogle Scholar
  8. Pincus, T., Hartley, J.W., and Rowe, W.P.: A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J. Exp. Med. 133: 1219–1233 (1971).PubMedCrossRefGoogle Scholar
  9. Sveda, M.M., Fields, B.N., and Soeiro, R.: Host restriction of Friend leukemia virus: fate of input virion RNA. Cell 2: 271–277 (1974).PubMedCrossRefGoogle Scholar
  10. Tennant, R.W., Schluter, B., Yang, W.-K., and Brown, A.: Reciprocal inhibition of mouse leukemia virus infection by Fv-1 allele cell extracts. Proc. Nat. Acad. Sci. U.S.A. 71: 4241–4245 (1974).CrossRefGoogle Scholar
  11. Wiener, F., Klein, G., and Harris, H.: The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. J. Cell Sci. 15 177–183 (1974).PubMedGoogle Scholar
  12. Wiener, F., Klein, G., and Harris, H.: The analysis of malignancy by cell fusion. VI. Hybrids between different tumour cells. J. Cell Sci. 16: 189–198 (1974).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Orlando J. Miller
    • 1
  1. 1.College of Physicians and SurgeonsColumbia UniversityNew YorkUSA

Personalised recommendations